BusinessMyriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDx® Test to Identify Patients with Germline BRCA Mutations for Rubraca® (rucaparib) TreatmentBy Nasdaq OMXApr 27, 2017, 11:05 AM UTC
BusinessBioSig Technologies to Attend the Heart Rhythm Society’s Scientific Sessions May 10-13 in ChicagoBy Nasdaq OMXApr 26, 2017, 12:02 PM UTC
BusinessBioSig Technologies to Attend the Heart Rhythm Society’s Scientific Sessions May 10-13 in ChicagoBy Nasdaq OMXApr 26, 2017, 12:02 PM UTC
BusinessBioSig Technologies to Attend the Heart Rhythm Society’s Scientific Sessions May 10-13 in ChicagoBy Nasdaq OMXApr 26, 2017, 12:02 PM UTC
BusinessIntegra LifeSciences Reports First Quarter 2017 Financial ResultsBy Nasdaq OMXApr 26, 2017, 10:00 AM UTC
BusinessAlder BioPharmaceuticals Presents Additional Data from Eptinezumab Development Program at 69th Annual American Academy of Neurology MeetingBy Nasdaq OMXApr 24, 2017, 12:31 PM UTC
BusinessAlder BioPharmaceuticals Presents Additional Data from Eptinezumab Development Program at 69th Annual American Academy of Neurology MeetingBy Nasdaq OMXApr 24, 2017, 12:31 PM UTC
